DeAnna Piatt Zacherl

Title: DeAnna Piatt Zacherl: Innovator in Pharmaceutical Compounds

Introduction

DeAnna Piatt Zacherl is a notable inventor based in Noblesville, IN (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that are beneficial for treating migraines. With a total of 3 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Her latest patents focus on compounds that activate 5-HT receptors and inhibit neuronal protein extravasation. These compounds are particularly useful for the treatment or prevention of migraines in mammals. The patents also detail processes for synthesizing intermediates necessary for creating these compounds, showcasing her innovative approach to pharmaceutical development.

Career Highlights

DeAnna is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation and research. Her work at Eli Lilly has allowed her to contribute to groundbreaking advancements in medicine, particularly in the area of migraine treatment.

Collaborations

Throughout her career, DeAnna has collaborated with esteemed colleagues such as Michael Philip Cohen and Daniel Timothy Kohlman. These collaborations have further enriched her research and development efforts, leading to impactful innovations in the pharmaceutical industry.

Conclusion

DeAnna Piatt Zacherl's contributions to the field of pharmaceuticals exemplify her dedication to innovation and improving healthcare outcomes. Her patents and work at Eli Lilly and Company highlight her role as a significant figure in the development of effective migraine treatments.